Infantile neuroaxonal dystrophy and pantothenate kinase-associated neurodegeneration: Locus heterogeneity

Neurology

Volumn 63, Issue 5, 2004, Pages 922-924

  Hortnagel K ^a   Nardocci, N ^b   Zorzi, G ^b   Garavaglia, B ^b   Botz, E ^a   Meitinger, T ^a,c   Klopstock, Thomas ^d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOTHENATE KINASE;

ALLELISM; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEVICE; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC HETEROGENEITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; NEUROAXONAL DYSTROPHY; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PRIORITY JOURNAL;

EID: 4644349437     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000137046.28085.B2     Document Type: Article

References (10)

1. Seitelberger F. Eine unbekannte Form von infantiler Lipoid-Speicher- Krankheit des Gehirns. In: Proceedings of the 1st International Congress of Neuropathology (Vol. 3). Turin: Rosenberg and Sellier, 1952;323-333.
2. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-349.
3. Ching KHL, Westaway SK, Gitschier J, Higgins JJ, Hayflick SJ. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Neurology 2002;58:1673-1674.
4. Farina L, Nardocci N, Bruzzone MG, et al. Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology 1999;41:376-380.
5. Nardocci N, Zorzi G, Farina L, et al. Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria. Neurology 1999;52:1472-1478.
6. Jellinger K, Seitelberger F, Rosenkranz W. [Infantile neuroaxonal dystrophy. Early form with preferential cerebellar involvement.] Acta Neuropathol 1968;10:123-131.
7. Cowen D, Olmstead EV. Infantile neuroaxonal dystrophy. J Neuropathol Exp Neurol 1963;22:175-236.
8. Malandrini A, Cavallaro T, Fabrizi GM, et al. Ultrastructure and immunoreactivity of dystrophic axons indicate a different pathogenesis of Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Virchows Arch 1995;427:415-421.
9. Bruno C, Bertini E, Federico A, et al. Clinical and molecular findings in patients with giant axonal neuropathy (GAN). Neurology 2004;62:13-16.
10. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33-40.